As of 2026-05-30, the EV/EBITDA ratio of Surgery Partners Inc (SGRY) is -31.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SGRY's latest enterprise value is 5,260.65 mil USD. SGRY's TTM EBITDA according to its financial statements is -169.30 mil USD. Dividing these 2 quantities gives us the above SGRY EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 13.3x | 9.6x |
| Forward P/E multiples | 8.9x - 11.1x | 10.4x |
| Fair Price | (35.27) - 13.21 | (14.54) |
| Upside | -364.0% - -1.1% | -208.8% |
| Date | EV/EBITDA |
| 2026-05-27 | -31.16 |
| 2026-05-26 | -31.14 |
| 2026-05-22 | -31.10 |
| 2026-05-21 | -31.02 |
| 2026-05-20 | -31.17 |
| 2026-05-19 | -31.33 |
| 2026-05-18 | -31.50 |
| 2026-05-15 | -31.52 |
| 2026-05-14 | -31.93 |
| 2026-05-13 | -31.80 |
| 2026-05-12 | -31.54 |
| 2026-05-11 | -31.39 |
| 2026-05-08 | -31.90 |
| 2026-05-07 | -31.80 |
| 2026-05-06 | -32.01 |
| 2026-05-05 | -31.76 |
| 2026-05-04 | -31.72 |
| 2026-05-01 | -31.77 |
| 2026-04-30 | -31.59 |
| 2026-04-29 | -31.46 |
| 2026-04-28 | -31.83 |
| 2026-04-27 | -31.97 |
| 2026-04-24 | -31.82 |
| 2026-04-23 | -32.04 |
| 2026-04-22 | -32.12 |
| 2026-04-21 | -32.01 |
| 2026-04-20 | -31.80 |
| 2026-04-17 | -31.56 |
| 2026-04-16 | -31.13 |
| 2026-04-15 | -30.97 |
| 2026-04-14 | -30.87 |
| 2026-04-13 | -30.87 |
| 2026-04-10 | -30.73 |
| 2026-04-09 | -30.75 |
| 2026-04-08 | -30.53 |
| 2026-04-07 | -30.52 |
| 2026-04-06 | -30.26 |
| 2026-04-02 | -30.17 |
| 2026-04-01 | -30.23 |
| 2026-03-31 | -29.97 |
| 2026-03-30 | -29.73 |
| 2026-03-27 | -29.64 |
| 2026-03-26 | -29.92 |
| 2026-03-25 | -30.07 |
| 2026-03-24 | -30.03 |
| 2026-03-23 | -30.02 |
| 2026-03-20 | -29.88 |
| 2026-03-19 | -30.07 |
| 2026-03-18 | -30.31 |
| 2026-03-17 | -30.53 |